
Newmont, Freeport-McMoRan, and Barrick Mining are the three Gold stocks to watch today, according to MarketBeat’s stock screener tool. Gold stocks are shares of companies whose primary business involves gold—typically miners, explorers, refiners, or royalty/streaming firms—whose revenues and valuations are linked to the metal. For investors, they offer leveraged exposure to the price of gold (and potential dividend income) but also carry company-specific risks such as operational, geopolitical, and production-cost variability. These companies had the highest dollar trading volume of any Gold stocks within the last several days.
Newmont (NEM)
Newmont Corporation engages in the production and exploration of gold. It also explores for copper, silver, zinc, and lead. The company has operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, Papua New Guinea, Ecuador, Fiji, and Ghana.
Freeport-McMoRan (FCX)
Freeport-McMoRan Inc. engages in the mining of mineral properties in North America, South America, and Indonesia. It primarily explores for copper, gold, molybdenum, silver, and other metals. The company's assets include the Grasberg minerals district in Indonesia; Morenci, Bagdad, Safford, Sierrita, and Miami in Arizona; Chino and Tyrone in New Mexico; and Henderson and Climax in Colorado, North America, as well as Cerro Verde in Peru and El Abra in Chile.
Read Our Latest Research Report on FCX
Barrick Mining (B)
Barrick Gold Corporation is a sector-leading gold and copper producer. Its shares trade on the New York Stock Exchange under the symbol GOLD and on the Toronto Stock Exchange under the symbol ABX.
In January 2019 Barrick merged with Randgold Resources and in July that year it combined its gold mines in Nevada, USA, with those of Newmont Corporation in a joint venture, Nevada Gold Mines, which is majority-owned and operated by Barrick.
Read Our Latest Research Report on B
Recommended Stories
- MarketBeat’s Top Five Stocks to Own in April 2026
- A Dividend King on Sale: Is Abbott Labs a Healthcare Bargain?
- Palantir Faces Skepticism Despite Strong Growth
- Compass Diversified’s $292M Sale Ignites Stock
- Spring Cleaning Your Portfolio: 4 Stocks With Rising Risks Heading Into Q2
- AMC’s Easter Surprise: A Bullish New Act?
